TARS
Tarsus Pharmaceuticals, Inc.
Price:  
49.25 
USD
Volume:  
364,958.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TARS WACC - Weighted Average Cost of Capital

The WACC of Tarsus Pharmaceuticals, Inc. (TARS) is 7.2%.

The Cost of Equity of Tarsus Pharmaceuticals, Inc. (TARS) is 7.25%.
The Cost of Debt of Tarsus Pharmaceuticals, Inc. (TARS) is 7.00%.

Range Selected
Cost of equity 5.90% - 8.60% 7.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.9% - 8.5% 7.2%
WACC

TARS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.44 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.90% 8.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.04 0.04
Cost of debt 7.00% 7.00%
After-tax WACC 5.9% 8.5%
Selected WACC 7.2%